chr13-50843502-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001306135.2(DLEU7):c.145G>A(p.Ala49Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000115 in 1,394,988 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001306135.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DLEU7 | NM_001306135.2 | c.145G>A | p.Ala49Thr | missense_variant | 1/2 | ENST00000504404.2 | |
DLEU7-AS1 | NR_046551.1 | n.438+3408C>T | intron_variant, non_coding_transcript_variant | ||||
DLEU7 | NM_198989.3 | c.145G>A | p.Ala49Thr | missense_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DLEU7 | ENST00000504404.2 | c.145G>A | p.Ala49Thr | missense_variant | 1/2 | 1 | NM_001306135.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151742Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000528 AC: 1AN: 18932Hom.: 0 AF XY: 0.0000837 AC XY: 1AN XY: 11954
GnomAD4 exome AF: 0.0000121 AC: 15AN: 1243246Hom.: 0 Cov.: 31 AF XY: 0.0000182 AC XY: 11AN XY: 604774
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151742Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74112
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2024 | The c.145G>A (p.A49T) alteration is located in exon 1 (coding exon 1) of the DLEU7 gene. This alteration results from a G to A substitution at nucleotide position 145, causing the alanine (A) at amino acid position 49 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at